INSIGHTS ON CLINICAL TRIAL PARTNERING

• The Next Frontier In Early Phase Oncology Trials

  This session explores the pivotal role of First-in-Human and early phase oncology trials in drug development, emphasizing the importance of comprehensive planning for successful execution.

• Optimizing The Path From First-In-Human To Proof-Of-Concept

  By collapsing the gaps between manufacturing and clinical trials and integrating these functions into a unified system, teams can adjust formulations in real-time and accelerate timelines.

• Routes To Sponsor Of Choice: Shared Pipelines, Streamlined Payments

  Paying clinical trial sites consistently on time provides stability and maintains positive relationships. Learn why being a sponsor of choice can mean the adoption of a singular clinical trial payments solution.

• Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call

  Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

• How Will The Ophthalmologist Shortage Impact Your Next Study?

  1/29/2025

  With a shortage of ophthalmologists affecting patients in both ophthalmic and non-ophthalmic clinical trials, the industry is looking for new solutions to ensure trial success and efficiency.

• Mergers And Acquisitions: How Institutional Knowledge Protecting Value

  5/27/2026

  M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.

• Increasing Efficiency And Reducing Drug Waste

  10/2/2025

  Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.

• Best Practices For Operationalizing Global, Early-Phase Oncology Trials

  9/10/2025

  In this presentation, industry experts will share real-world lessons learned from managing global early-phase oncology trials.

• Retention Through Intention — Designing Truly Patient-Centric Trials

  2/4/2026

  High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.